--- title: "Harmony Biosciences|8-K:2025 财年 Q3 营收 2.39 亿美元超过预期" type: "news" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/262433821.md" published_at: "2025-10-23T12:16:12.000Z" --- # Harmony Biosciences|8-K:2025 财年 Q3 营收 2.39 亿美元超过预期 营收:截至 2025 财年 Q3,公布值为 2.39 亿美元,市场一致预期值为 2.2 亿美元,超过预期。 ### 财务指标概述 #### 收入 - WAKIX®(匹托利桑)特许经营在 2025 年第三季度实现净收入约 2.39 亿美元,同比增长 29%。 #### 运营指标 - 该季度的患者平均数量增加了约 500 人,达到 8,100 名患者,推动了 WAKIX 在嗜睡症领域的潜在重磅药物地位。 #### 前景/指导 - 公司将 2025 年的收入指导从之前的 8.2 亿至 8.6 亿美元上调至 8.45 亿至 8.65 亿美元。 - 这些前瞻性声明基于管理层当前的意见、预期、信念、计划、目标、假设或对未来事件或结果的预测。 - 实际结果、活动水平、绩效、成就和事件可能与这些前瞻性声明中所述、预期或暗示的内容有重大差异。 ### Related Stocks - [HRMY.US - Harmony Biosciences](https://longbridge.com/zh-CN/quote/HRMY.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | 14:57 ETQvinci and Harmonyze Announce Strategic Partnership to Elevate Franchise Performance Coaching | Qvinci Software and Harmonyze have announced a strategic partnership aimed at enhancing franchise performance coaching. | [Link](https://longbridge.com/zh-CN/news/275651785.md) | | Sandip Kapadia Sells 3,746 Shares of Harmony Biosciences (NASDAQ:HRMY) Stock | CFO Sandip Kapadia of Harmony Biosciences sold 3,746 shares at $37.15 each, totaling $139,163.90, reducing his ownership | [Link](https://longbridge.com/zh-CN/news/274076411.md) | | Assessing Harmony Biosciences (HRMY) Valuation As Growth, Financial Strength And Technical Signals Attract Investors | Harmony Biosciences (HRMY) is attracting investor interest due to its revenue and earnings growth, solid financial posit | [Link](https://longbridge.com/zh-CN/news/273826298.md) | | Harmony Biosciences CFO Sandip Kapadia Reports Disposal of Common Shares | Sandip Kapadia, CFO of Harmony Biosciences Holdings Inc., reported the disposal of common shares of the company. The ful | [Link](https://longbridge.com/zh-CN/news/274069011.md) | | Harmony Biosciences CFO Sells Over 20K Shares | Harmony Biosciences CFO Sandip Kapadia sold 20,961 shares of common stock on January 15, 2026, at a weighted average pri | [Link](https://longbridge.com/zh-CN/news/273157191.md) | --- > **免责声明**:本文内容仅供参考,不构成任何投资建议。